Developments in nutraceuticals

Indian Journal of Pharmacology

Volumn 35, Issue 6, 2003, Pages 363-372

  Dureja, Harish ^a   Kaushik, D ^a   Kumar, V ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

Dietary supplements; Herbals; Nutrients

Indexed keywords

AJOENE; ALOE VERA EXTRACT; ANTIDEPRESSANT AGENT; APPETITE INTERCEPT; BIOVINCA; CALCIROL D 3; CERNITIN; CHAMOMILE; CHASER; ECHINACEA EXTRACT; ELEUTHERA EXTRACT; EPHEDRA EXTRACT; GARLIC EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GOLDENSEAL EXTRACT; GRD; HERBACEOUS AGENT; HOREHOUND EXTRACT; HYPERICUM PERFORATUM EXTRACT; ISPAGULA; KAVA EXTRACT; LICORICE EXTRACT; MELISSA OFFICINALIS EXTRACT; MUSHROOM OPTIMIZER; PNER PLUS; PRIMROSE OIL; PROPLUS; PROTEINEX; PYGEUM AFRICUM EXTRACT; ROX; SABAL EXTRACT; SITOSTEROL; SLIPPERY ELM EXTRACT; TANACETUM PARTHENIUM EXTRACT; THREPTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN; VINPOCETINE; WEIGHT SMART; WELLIFE; WILLOW BARK EXTRACT;

ACUTE DISEASE; ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ANGINA PECTORIS; ANTIBODY TITER; ANXIETY; ASTHMA; ATHEROSCLEROSIS; CANCER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; COMMON COLD; DEMENTIA; DEPRESSION; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG FATALITY; EXERCISE; FOOD DRUG INTERACTION; GARLIC; GENETIC PREDISPOSITION; HEALTH CARE QUALITY; HEPATITIS B; HERBAL MEDICINE; HONEYBEE; HUMAN; HYPERTENSION; INFLUENZA; INTERMITTENT CLAUDICATION; LIPID OXIDATION; NONHUMAN; NUTRIENT; OSTEOARTHRITIS; PANCREAS CANCER; PARKINSON DISEASE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SKIN CANCER; TETANUS; TREATMENT FAILURE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VITAMIN SUPPLEMENTATION;

EID: 0344234440     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Biesalski HK. Nutraceuticals: The link between nutrition and medicine. In: Kramer K, Hoppe PP, Packer L, editors. Nutraceuticals in Health and Disease Prevention. New York: Marcel Dekker Inc.; 2001. p. 1-26.
2. Andlauer W, Furst P. Nutraceuticals: A piece of history, present status and outlook. Food Research International 2002;35:171-6.
3. Whitman M. Understanding the perceived need for complementary and alternative nutraceuticals: Lifestyle issues. Clin J Oncol Nurs 2001;5:190-4.
4. Stauffer JE. Nutraceuticals. Cereal Foods World 1999;44:115-7.
5. Roberfroid MB. Global view on functional foods: European perspectives. Br J Nutr 2002;88:133-8.
6. Gibson RA, Makrides M. n-3 Polyunsaturated fatty acid requirements of term infants. Am J Clin Nutr 2000;71:251-5.
7. Stephen AM. Regulatory aspects of functional products, In: Mazza G, editor. Functional Foods: Biochemical and Processing Aspects. Basel: Lancaster; 1998.
8. Hathcock J. Dietary supplements: How they are used and regulated. J Nutrition 2001;131:1114-7.
9. Mobarhan S. Micronutrient supplementation trials and the reduction of cancer and cerebrovascular incidences and mortality. Nutr Rev 1994;52:102-5.
10. Rijk MC, Breteler MMB, Breeijen JH, Launer LJ, Grobbee DE, Van Der Meche FG, et al. Dietary antioxidants and parkinson's disease, The Rotterdam study. Arch Neurol 1997;54:762-5.
11. Agus DB, Gambhir SS, Pardridge WM, Spielholz C, Baselga J, Vera JC, et al. Vitamin C crosses the blood brain barrier in the oxidized form through the glucose transporters. J Clin Invest 1997;100:2842-8.
12. Jialal I, Fuller CJ. Effect of vitamin E, vitamin C and beta carotene on the LDL oxidation and atherosclerosis. Can J Cardiol 1995;11:97-103.
13. Klein C, Sato T, Meguid MM, Miyata G. From food to nutritional support to specific nutraceuticals: A journey across time in the treatment of disease. J Gastroenterol 2000;35:1-6.
14. Burney PG, Comstock GW, Morris JS. Serologic precursors of cancer: Serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 1989;49:895-900.
15. Mathew P, Wyllie R, Van Lente F, Steffen RM, Kay MH. Antioxidants in hereditary pancreatitis. Am J Gastroenterol 1996;91:1558-62.
16. Clark LC, Combs Jr. GF, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-63.
17. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 1997;80:331-3.
18. Allen LV. Nutritional products, In: Covington TR, Berardi RR, Young LL, Kendall SC, Hickey MJ, editors. Handbook of Nonprescription Drugs. Washington DC: American Pharmaceutical Association; 1997.
19. Tyler VE, Foster F. Herbs and phytochemicals, In: Covington TR, Berardi RR, Young LL, Kendell SC, Hickey MJ, editors. Handbook of Nonprescription Drugs. Washington DC: American Pharmaceutical Association; 1996.
20. Braeckman J. The Extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open study. Curr Ther Res 1994;55:776-85.
21. Melchart D, Linde K, Worku F, Sarkady L, Holzmann M, Jurcic K, et al. Results of five randomized studies on the immunomodulatory activity of preparation of Echinacea. J Alt Complement Med 1995;1:145-60.
22. Ernst E. The risk-benefit of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, saw Palmetto, and Kava. Ann Intern Med 2002;136:42-53.
23. Ernst E. Second thoughts on the safety of St. John's wort. Lancet 1999;345:2014-16.
24. Mai I, Krugert H, Budde K, Johne A, Brockmoller J, Neumayer HH, et al. Hazardous pharmacokinetic interactions of St. John's wort with the immunosuppresant cyclosporine. Int J Clin Pharmacol Ther 2000;38:500-2.
25. Ernst E, Pittler MH. Ginkgo biloba for dementia. A systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999;17:301-8.
26. Mix JA, Crews WD. An examination of the efficacy of ginkgo biloba extract EGb 761 on the neurophysiologic functioning of cognitively intact older adults. J Alt Complement Med 2000;6:219-9.
27. Canter PH, Ernst E. Ginkgo biloba: A smart drug? A systematic review of controlled trials of the cognitive effects of ginkgo biloba extracts in healthy people. Psychopharmacol Bull 2002;36:108-23.
28. Craig W, Beck L. Phytochemicals: Health Protective Effects. Can J Diet Pract Res 1999;60:78-84.
29. Awad AB, Fink CS. Phytosterols as anticancer dietary components: Evidence and mechanism of action. Nutrition 2000;130:2127-30.
30. Silagy C, Neil A. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994;12:463-8.
31. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia, A meta-analysis of randomized clinical trials. Ann Intern Med 2000;133:420-9.
32. Sener G, Satyroglu H, Ozer Sehirli A, Kacmaz A. Protective effect of aqueous garlic extract against oxidative organ damage in a rat model of thermal injury. Life Sci 2003;73:81-91.
33. Teranishi K, Apitz-Castro R, Robson SC, Romano E, Cooper DK. Inhibition of baboon platelet aggregation in vitro and in vivo by the garlic derivative, ajoene. Xenotransplantation 2003;10:374-9.
34. Sengupta A, Ghosh S, Das S. Tomato and garlic can modulate azoxymethane-induced colon carcinogenesis in rats. Eur J Cancer Prev 2003;12:195-200.
35. Thatte U, Bagadey S, Dahanukar S. Modulation of programmed cell death by medicinal plants. Cell Mol Biol 2000;46:199-214.
36. Villasenor IM, Simon MK, Villanueva AM. Comparative potencies of nutraceuticals in chemically induced skin tumour prevention. Nutr Cancer 2002;44:66-70.
37. Schwartz JB. Nutraceuticals: Sorting out fact, fiction and uncertainity. J Gend Specific Med 2000;3:30-7.
38. McCarron DA, Oparil S, Chait A, et al. Nutritional management of cardiovascular risk factors. Arch Intern Med 1997;157:169-77.
39. Chapman DP, Giles WH. Pharmacologic and dietary therapies in epilepsy: Conventional treatments and recent advances. South Med J 1997;90:471-80.
40. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997;277:472-7.
41. Slavin J, Jacobs D, Marquart L. Whole grain consumption and chronic disease: Protective mechanisms. Nutr Cancer 1997;27:14-21.
42. Chang R. Functional properties of edible mushrooms. Nutr Rev 1996;54:91-3.
43. Kaufman FR, Halvorson M, Kaufman ND. A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp. Diabetes Res Clin Pract 1995;30:205-9.
44. Kaufman FR. Zbar as part of the diabetes regimen. Clin Res Reg Aff 1997;14:75-82.
45. Stadelman WJ. The incredibly functional egg. Poult Sci 1999;78:807-11.
46. Reyes GC, Koda RT, Lein EJ. Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: A survey. Prog Drug Res 2000;55:81-103.
47. Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999;25:379-95.
48. FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-1-converting enzyme. Br J Nutr 2000;84:33-7.
49. Korhonen H, Marnila P, Gill HS. Bovine milk antibodies for health. Br J Nutr 2000;84:135-46.
50. Li SQ, Zhang QH. Advances in the development of functional foods from buckwheat. Crit Rev Food Sci Nutr 2001;4:451-64.
51. Morelli L. Probiotics: Clinics and/or nutrition. Dig Liver Dis 2002;34:8-11.
52. Sayegh R, Schiff I, Wuetman J, Spires P, McDermott J, Wurtman R. The effect of a carbohydrate-rich beverage on mood, appetite and cognitive function in women with premenstrual syndrome. Obstet Gynecol 1995;86:520-8.
53. Mei Y, Zhou Y. Barrier and mechanical properties of milk protein based edible films containing nutraceuticals. J Agric Food Chem 2003;51:1914-18.
54. Madley-Wright R. New products. Nutraceutical World 2003;6:66-71.
55. Madley-Wright R. New products. Nutraceutical World 2003;6:118-25.
56. Chang J. Medicinal herbs: Drugs or dietary supplements? Biochem Pharmacol 2000;59:211-19.
57. Halt M. Moulds and mycotoxins in herb tea and medicinal plants. Eur J Epidemiol 1998;14:269-74.
58. Ernst E. Functional foods, nutraceuticals, designer foods: Innocent fad or counterproductive marketing ploy. Eur J Clin Pharmacol 2001;57:353-5.
59. Hardy G, Hardy I, McElory B. Nutraceuticals: A pharmaceutical viewpoint: I. Curr Opin Clin Metab Care 2002;5:671-77.
60. Bass IS, Young AL. Dietary Supplements Health and Education Act. Washington DC: The Food and Drug Law Institute; 1996.